TARKA - RxAbbVie
... across age groups (<65, ≥65 years), and gender (male, female). Blood pressure reductions were significantly greater for the TARKA 4/240 combination than for either of the components used alone. The antihypertensive effects of TARKA have continued during therapy for at least 1 year. INDICATIONS AND U ...
... across age groups (<65, ≥65 years), and gender (male, female). Blood pressure reductions were significantly greater for the TARKA 4/240 combination than for either of the components used alone. The antihypertensive effects of TARKA have continued during therapy for at least 1 year. INDICATIONS AND U ...
VIOXX® - Merck.com
... phonophobia were also assessed. Maintenance of relief was assessed for up to 24 hours postdose. Other medication, with the exception of NSAIDs (including COX-2 inhibitors) or combination medications that contained NSAIDs, was permitted from 2 hours after the dose of study medication. The frequency a ...
... phonophobia were also assessed. Maintenance of relief was assessed for up to 24 hours postdose. Other medication, with the exception of NSAIDs (including COX-2 inhibitors) or combination medications that contained NSAIDs, was permitted from 2 hours after the dose of study medication. The frequency a ...
Emerging treatment options for excessive sleepiness associated
... normal function. Although scheduled naps are helpful in combating ES, pharmacological therapy is often needed. Modafinil (Provigil®), a novel wake-promoting agent, is considered by the American Academy of Sleep Medicine in evidence-based guidelines to be a standard therapy for improving wakefulness ...
... normal function. Although scheduled naps are helpful in combating ES, pharmacological therapy is often needed. Modafinil (Provigil®), a novel wake-promoting agent, is considered by the American Academy of Sleep Medicine in evidence-based guidelines to be a standard therapy for improving wakefulness ...
Predictors of neonatal abstinence syndrome in
... State University, Johnson City, TN, USA Full list of author information is available at the end of the article ...
... State University, Johnson City, TN, USA Full list of author information is available at the end of the article ...
National report 2014: Poland - European Monitoring Centre for
... Poleganow, A., Radomska, A., Struzik, M., Stawecka, E., Struzik, M., Strzelecka, A., Twierdziańska, A., Walichnowska, M. (2015), National Drug Report 2014 Poland, Krajowe Biuro ds. Przeciwdziałania Narkomanii, Warsaw ...
... Poleganow, A., Radomska, A., Struzik, M., Stawecka, E., Struzik, M., Strzelecka, A., Twierdziańska, A., Walichnowska, M. (2015), National Drug Report 2014 Poland, Krajowe Biuro ds. Przeciwdziałania Narkomanii, Warsaw ...
Appendix D: Commonly Used Antihypertensive Drugs 1
... PharmaCare Coverage Definitions: G: generic(s) are available; Regular Coverage: also known as regular benefit; does not require Special Authority. Regular benefits may be fully or partially covered.*; Limited Coverage: requires Special Authority for coverage. Limited Coverage benefits approved by Sp ...
... PharmaCare Coverage Definitions: G: generic(s) are available; Regular Coverage: also known as regular benefit; does not require Special Authority. Regular benefits may be fully or partially covered.*; Limited Coverage: requires Special Authority for coverage. Limited Coverage benefits approved by Sp ...
Ranzith®
... Avoid concomitant administration with terfenadine or astemazole. Precaution should be taken in patients with severe renal impairment. Overdosage There is no data on over dosage with Azithromycin. Typical symptoms of over dosage with macrolide antibiotics include hearing loss, severe nausea, vomiting ...
... Avoid concomitant administration with terfenadine or astemazole. Precaution should be taken in patients with severe renal impairment. Overdosage There is no data on over dosage with Azithromycin. Typical symptoms of over dosage with macrolide antibiotics include hearing loss, severe nausea, vomiting ...
Vol 6 No 4
... stance to attain the proper tonicity range. Sodium chloride, boric acid and dextrose are commonly used. Three hundred mOsm/L is ideal with 200-600 mOsm/L acceptable. pH and Buffering-Ophthalmic solutions are ordinarily buffered at the pH of maximum stability for the drug(s) they contain. The buffer ...
... stance to attain the proper tonicity range. Sodium chloride, boric acid and dextrose are commonly used. Three hundred mOsm/L is ideal with 200-600 mOsm/L acceptable. pH and Buffering-Ophthalmic solutions are ordinarily buffered at the pH of maximum stability for the drug(s) they contain. The buffer ...
Can methylphenidate be used for adults with attention deficit
... Evidence based guidelines for the pharmacological management of ADHD from the British Association for Psychopharmacology in 2014 recommend use of methylphenidate as a first line stimulant drug. Response to treatment should be assessed in follow up visits using rating scales to objectively check symp ...
... Evidence based guidelines for the pharmacological management of ADHD from the British Association for Psychopharmacology in 2014 recommend use of methylphenidate as a first line stimulant drug. Response to treatment should be assessed in follow up visits using rating scales to objectively check symp ...
Loxamine - Medsafe
... moderate, however, in some patients they may be severe in intensity. They usually occur within the first few days of discontinuing treatment, but there have been very rare reports of such symptoms in patients who have inadvertently missed a dose. Generally these symptoms are self-limiting and usuall ...
... moderate, however, in some patients they may be severe in intensity. They usually occur within the first few days of discontinuing treatment, but there have been very rare reports of such symptoms in patients who have inadvertently missed a dose. Generally these symptoms are self-limiting and usuall ...
hydromorphone hydrochloride ciir
... Gastrointestinal System: Nausea, and vomiting occur infrequently; they are more frequent in ambulatory than in recumbent patients. The antiemetic phenothiazines are useful in suppressing these effects; however, some phenothiazine derivatives seem to be antianalgesic and to increase the amount of nar ...
... Gastrointestinal System: Nausea, and vomiting occur infrequently; they are more frequent in ambulatory than in recumbent patients. The antiemetic phenothiazines are useful in suppressing these effects; however, some phenothiazine derivatives seem to be antianalgesic and to increase the amount of nar ...
AusPAR: Doxycycline monohydrate
... This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and reta ...
... This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and reta ...
ALDORIL - methyldopa and hydrochlorothiazide
... It is important to recognize that a positive Coombs test, hemolytic anemia, and liver disorders may occur with methyldopa therapy. The rare occurrences of hemolytic anemia or liver disorders could lead to potentially fatal complications unless properly recognized and managed. Read this section caref ...
... It is important to recognize that a positive Coombs test, hemolytic anemia, and liver disorders may occur with methyldopa therapy. The rare occurrences of hemolytic anemia or liver disorders could lead to potentially fatal complications unless properly recognized and managed. Read this section caref ...
Nausea and vomiting after surgery
... Dimenhydrinate is an antihistamine like promethazine and cyclizine. There are few randomized controlled trials investigating its use for PONV, and the drug is associated with a significant rate of side-effects like sedation, dry mouth, visual disturbance, and urinary retention. Transdermal scopolami ...
... Dimenhydrinate is an antihistamine like promethazine and cyclizine. There are few randomized controlled trials investigating its use for PONV, and the drug is associated with a significant rate of side-effects like sedation, dry mouth, visual disturbance, and urinary retention. Transdermal scopolami ...
OMNARIS Full Prescribing Information
... reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety data described below for adults and adolescents 12 years of age and older are based on 3 clinical trials of ...
... reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety data described below for adults and adolescents 12 years of age and older are based on 3 clinical trials of ...
Journal of Affective Disorders
... of interests interests . . . . . . . Conflicts References . . . . . . . . . . . ...
... of interests interests . . . . . . . Conflicts References . . . . . . . . . . . ...
Doctor Discussion Guide
... Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). GEODON is not approved for treating these patients. GEODON may increase the risk ...
... Elderly patients with dementia-related psychosis (having lost touch with reality due to confusion and memory loss) treated with this type of medicine are at an increased risk of death, compared to placebo (sugar pill). GEODON is not approved for treating these patients. GEODON may increase the risk ...
LIPOSOMES FOR THE DELIVERY OF NUCLEIC ACID DRUGS A
... fusogenic lipids on NA delivery to target tissue from their effect on intracellular delivery. Fusogenic formulations are more likely to interact with the vascular endothelium, blood cells, lipoproteins, and other non target systems while in the blood compartment. For this reason there may be an adv ...
... fusogenic lipids on NA delivery to target tissue from their effect on intracellular delivery. Fusogenic formulations are more likely to interact with the vascular endothelium, blood cells, lipoproteins, and other non target systems while in the blood compartment. For this reason there may be an adv ...
sinemet cr - Merck.com
... myocardial infarction who have residual atrial, nodal, or ventricular arrhythmias. In such patients, cardiac function should be monitored with particular care during the period of initial dosage adjustment, in a facility with provisions for intensive cardiac care. As with levodopa, treatment with SI ...
... myocardial infarction who have residual atrial, nodal, or ventricular arrhythmias. In such patients, cardiac function should be monitored with particular care during the period of initial dosage adjustment, in a facility with provisions for intensive cardiac care. As with levodopa, treatment with SI ...
U.S. Prescribing Information
... Serum digoxin levels less than 0.5 ng/mL have been associated with diminished efficacy, while levels above 2 ng/mL have been associated with increased toxicity without increased benefit. Interpret the serum digoxin concentration in the overall clinical context, and do not use an isolated measurement ...
... Serum digoxin levels less than 0.5 ng/mL have been associated with diminished efficacy, while levels above 2 ng/mL have been associated with increased toxicity without increased benefit. Interpret the serum digoxin concentration in the overall clinical context, and do not use an isolated measurement ...
Impact of levalbuterol versus Albuterol in Kentucky Medicaid Patients
... treatment of asthma. Racemic albuterol has been used for more than 40 years but is associated with several side effects including tremor. When levalbuterol was approved in 2005 its manufacturer and several studies suggested that using levalbuterol results in better respiratory parameters, fewer hosp ...
... treatment of asthma. Racemic albuterol has been used for more than 40 years but is associated with several side effects including tremor. When levalbuterol was approved in 2005 its manufacturer and several studies suggested that using levalbuterol results in better respiratory parameters, fewer hosp ...
AusPAR: Pitavastatin - Therapeutic Goods Administration
... organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are ...
... organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are ...
Wellbutrin - GSK Source
... Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (selective serotonin reuptake inhibitors [SSRIs] and others) show that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with MDD and ...
... Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (selective serotonin reuptake inhibitors [SSRIs] and others) show that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with MDD and ...
An update on the management of chronic hepatitis C:
... requires a multidisciplinary approach that includes experienced physicians, nurses and allied health professionals (eg, psychologists, psychiatrists, addiction specialists and social workers). Currently in Canada, a relatively small number of physicians treat hepatitis C, leading in some cases to pr ...
... requires a multidisciplinary approach that includes experienced physicians, nurses and allied health professionals (eg, psychologists, psychiatrists, addiction specialists and social workers). Currently in Canada, a relatively small number of physicians treat hepatitis C, leading in some cases to pr ...
Bad Pharma
.JPG?width=300)
Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients is a book by British physician and academic Ben Goldacre about the pharmaceutical industry, its relationship with the medical profession, and the extent to which it controls academic research into its own products. The book was published in September 2012 in the UK by the Fourth Estate imprint of HarperCollins, and in February 2013 in the United States by Faber and Faber.Goldacre argues in the book that ""the whole edifice of medicine is broken"" because the evidence on which it is based is systematically distorted by the pharmaceutical industry. He writes that the industry finances most of the clinical trials into its own products and much of doctors' continuing education, that clinical trials are often conducted on small groups of unrepresentative subjects and negative data is routinely withheld, and that apparently independent academic papers may be planned and even ghostwritten by pharmaceutical companies or their contractors, without disclosure. Goldacre calls the situation a ""murderous disaster,"" and makes suggestions for action by patients' groups, physicians, academics and the industry itself.Responding to the book's publication, the Association of the British Pharmaceutical Industry issued a statement arguing that the examples the book offers are historical, that the concerns have been addressed, that the industry is among the most regulated in the world, and that it discloses all data in accordance with international standards.In January 2013 Goldacre joined the Cochrane Collaboration, British Medical Journal and others in setting up AllTrials, a campaign calling for the results of all past and current clinical trials to be reported. The British House of Commons Public Accounts Committee expressed concern in January 2014 that drug companies were still only publishing around 50 percent of clinical-trial results.